Christophe P.
- Country
- France
- Department
- Oncologie Médicale
Research Overview
- De-escalation of endocrine therapy in postmenopausal women with low-risk HR+ HER2- low Luminal A early breast cancer: a single-arm study of omission versus combination therapy
- Phase IIb/III Randomized Controlled Study of Lurbinectedin Plus Doxorubicin Versus Doxorubicin Monotherapy in Metastatic Leiomyosarcoma Patients
- Long-term Safety Evaluation of Oral Brigimadlin Monotherapy in Patients with Solid Tumors: A Phase II, Single-Arm, Open-Label Rollover Study
Data & Insights
Has run more than one trial at 97 of 277 partner sites.
Specializations
Sarcoma Research
The investigator specializes in treating various forms of sarcomas, with particular emphasis on osteosarcoma and soft tissue sarcomas.
- High-grade osteosarcoma management
- Metastatic and unresectable sarcomas
- Bone sarcoma therapeutics
- Leiomyosarcoma treatment approaches
Their work extends to rare sarcoma subtypes and advanced molecular profiling techniques for personalized treatment strategies.
Breast Cancer Treatment
The investigator focuses on innovative approaches in breast cancer treatment, particularly in hormone-sensitive cases and genetic mutations.
- Hormone therapy optimization
- BRCA-mutated breast cancer
- Luminal A breast cancer management
- Post-menopausal breast cancer care
Their research encompasses adjuvant therapy strategies and targeted treatments for specific patient populations.
Advanced Therapeutic Approaches
The investigator explores innovative therapeutic combinations and novel treatment strategies across multiple cancer types.
- Immunotherapy applications
- Molecular profiling integration
- Combination therapy development
- Risk-adapted treatment strategies
Their work includes evaluating new therapeutic agents and optimizing treatment protocols for improved patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.